More than half of women prescribed drugs for overactive bladder discontinue treatment after 6 months.
More than half of women prescribed anticholinergic drugs for lower urinary tract symptoms suggestive of overactive bladder discontinued treatment after 6 months, suggesting poor adherence to treatment, researchers report in the December issue of Obstetrics and Gynecology.
Manish Gopal, MD, and colleagues from the University of Pennsylvania in Philadelphia analyzed discontinuation rates of anticholinergic medications used to treat lower urinary tract symptoms using data from 49,419 episodes of anticholinergic therapy from 29,369 women in the United Kingdom.
The researchers found that women discontinued the drugs after a median of 4.76 months. At 6 months, 58.8% of women had discontinued treatment and 77.2% had discontinued after 1 year. At 6 months, 71% had discontinued oxybutynin, 57% had discontinued extended-release oxybutynin, 61% had discontinued tolterodine tartrate, and 54% had discontinued extended-release tolterodine tartrate, the report indicates. Women switched to another medication in 15.8% of episodes. There were an average of 1.65 treatment episodes and an average of 1.54 drug classes prescribed per patient, the authors report.
Gopal M, Haynes K, Bellamy SL, et al. Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol. 2008;112:1311-1318.
Removing parental consent reduces delays in adolescent abortion care
February 12th 2025A new study links the removal of parental consent requirements for abortion in Massachusetts to significantly earlier gestational age at the time of the procedure, highlighting the impact of reduced barriers on timely reproductive care.
Read More
Variations reported in state-level maternal death causes
February 11th 2025A recent study highlights significant variations in pregnancy-related deaths across US states, emphasizing the need for targeted policies to address homicide, suicide, and drug overdose among pregnant and postpartum individuals.
Read More
AI analysis reveals key risk factors for severe pregnancy outcomes
February 11th 2025A new artificial intelligence-based study found risk factor combinations linked to severe adverse pregnancy outcomes, offering a more personalized and transparent approach to risk assessment in obstetrics.
Read More